1.Chronic myeloid leukaemia presenting as priapism- how should we treat these?
Htun TH ; Dublin N ; Parameswaran M ; Razack AH ; Chua CB
Journal of University of Malaya Medical Centre 2008;11(1):27-29
Priapism is a urological emergency. The treatment for ischaemic priapism is usually
cavernosal aspiration with or without cavernosal irrigation. Some patients may need surgical intervention
-the various shunt procedures. We report a 21-year-old man with priapism secondary to chronic
myeloid leukemia who needed a combined medical and surgical management. He underwent a spongiocavernosal
shunt as well as cytoreductive chemotherapy to achieve complete detumescence. Therefore,
cytoreductive chemotherapy is an adjunct in diffi cult to treat priapism associated with chronic myeloid
leukemia
Leukemia, Myeloid
2.Epidural Granulocytic Sarcoma Causing Cord Compression at Thoracic Region in Acute Myelogenous Leukemia: A Case Report.
Woo Min PARK ; Jee Soo JANG ; Chang Hun RHEE ; Ho Shin GWAK ; Seung Hoon LEE
Journal of Korean Neurosurgical Society 2000;29(11):1533-1537
No abstract available.
Leukemia, Myeloid, Acute*
;
Sarcoma, Myeloid*
3.Sumary of the duration of the phase transfer of chronic myeloid leukemia
Journal of Vietnamese Medicine 2001;257(3):1-4
A restrospective study carried out on 309 patients with chronic myelogenous leukemia treated from 1990 to 10/2000 showed that; -88 cases (28.3%) converted to the blast crisis. - 89.77% of these cases developed acute myeloblastic leukemia (AML) and 9.09% developed ALL.-The percentage of male and female were 55.68% and 44.31% - 45.45% of these converted cases occurred in the age group of 30-50. The youngest age was 10 months and the oldest age was : 72 years old. Mean of duration of the chronic phase was 2.5 years.
Leukemia, Myeloid, Chronic
;
Leukemia, Myeloid, Chronic-Phase
4.A case of familial acute myelogenous leukemia.
Hyun Choon SHIN ; Jin Hak LEE ; Hyuk Pyo LEE ; Tae Hyun UM ; Han Ik CHO ; Seon Yang PARK ; Hyo Seop AHN ; Byoung Kook KIM ; Noe Kyoung KIM ; Kyoung Sik OH ; Myoung Soo LYOU
Korean Journal of Medicine 1993;45(3):388-395
No abstract available.
Leukemia, Myeloid, Acute*
5.The clinical significance of cytogenetics in acute myelogenous leukemia.
Korean Journal of Medicine 2002;62(6):597-599
No abstract available.
Cytogenetics*
;
Leukemia, Myeloid, Acute*
6.Acute myeloid leukemia with t(4;12)(q12;p13): report of 2 cases.
Kyung Hee KIM ; Moon Jin KIM ; Jeong Yeal AHN ; Pil Whan PARK ; Yiel Hea SEO ; Ji Hun JEONG
Blood Research 2016;51(2):133-137
No abstract available.
Leukemia, Myeloid, Acute*
7.A case of weakened group B antigen in a patient with acute myeloblastic leukemia.
Chaeseung LIM ; Yunjeong CHO ; Youngkee KIM
Korean Journal of Blood Transfusion 1991;2(2):211-214
No abstract available.
Humans
;
Leukemia, Myeloid, Acute*
8.Risk-adopted therapy for acute myelogenous leukemia.
Korean Journal of Medicine 2005;69(2):126-134
No abstract available.
Leukemia, Myeloid, Acute*
9.Acute Myelogenous Leukemia.
Korean Journal of Pediatrics 2004;47(Suppl 2):S359-S366
No abstract available.
Leukemia, Myeloid, Acute*
10.Treatment of Acute Myelogenous Leukemia.
Korean Journal of Pediatric Hematology-Oncology 1999;6(2):222-234
No available abstract.
Leukemia, Myeloid, Acute*
Result Analysis
Print
Save
E-mail